Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Page 1
Mucosal-associated invariant T-cell tumor infiltration predicts long-term survival in cholangiocarcinoma.
Zimmer CL, Filipovic I, Cornillet M, O'Rourke CJ, Berglin L, Jansson H, Sun D, Strauss O, Hertwig L, Johansson H, von Seth E, Sparrelid E, Dias J, Glaumann H, Melum E, Ellis EC, Sandberg JK, Andersen JB, Bergquist A, Björkström NK. Zimmer CL, et al. Among authors: glaumann h. Hepatology. 2022 May;75(5):1154-1168. doi: 10.1002/hep.32222. Epub 2021 Dec 22. Hepatology. 2022. PMID: 34719787
Finally, the high presence of MAIT cells in livers of iCCA patients predicted long-term survival in two independent cohorts and was associated with a favorable antitumor immune signature. ...
Finally, the high presence of MAIT cells in livers of iCCA patients predicted long-term survival in two independent cohorts and was a …
Long-term follow-up of successful hepatitis C virus therapy: waning immune responses and disappearance of liver disease are consistent with cure.
Hedenstierna M, Weiland O, Brass A, Bankwitz D, Behrendt P, Uhnoo I, Aleman S, Cardell K, Fryden A, Norkrans G, Eilard A, Glaumann H, Pietschmann T, Sällberg M, Brenndörfer ED. Hedenstierna M, et al. Among authors: glaumann h. Aliment Pharmacol Ther. 2015 Mar;41(6):532-43. doi: 10.1111/apt.13096. Epub 2015 Jan 28. Aliment Pharmacol Ther. 2015. PMID: 25627143 Free article.
CONCLUSIONS: Our combined data confirm that a SVR corresponds to a long-term clinical cure. The waning immune responses support the disappearance of the antigenic stimulus. ...
CONCLUSIONS: Our combined data confirm that a SVR corresponds to a long-term clinical cure. The waning immune responses support the d …
Decreased survival of subjects with elevated liver function tests during a 28-year follow-up.
Söderberg C, Stål P, Askling J, Glaumann H, Lindberg G, Marmur J, Hultcrantz R. Söderberg C, et al. Among authors: glaumann h. Hepatology. 2010 Feb;51(2):595-602. doi: 10.1002/hep.23314. Hepatology. 2010. PMID: 20014114
The long-term survival of subjects with nonalcoholic fatty liver disease (NAFLD) in comparison with both individuals with elevated transaminases attributable to other causes and the general poulation is poorly characterized. ...
The long-term survival of subjects with nonalcoholic fatty liver disease (NAFLD) in comparison with both individuals with elevated tr …
High prevalence of small duct primary sclerosing cholangitis among patients with overlapping autoimmune hepatitis and primary sclerosing cholangitis.
Olsson R, Glaumann H, Almer S, Broomé U, Lebrun B, Bergquist A, Björnsson E, Prytz H, Danielsson A, Lindgren S. Olsson R, et al. Among authors: glaumann h. Eur J Intern Med. 2009 Mar;20(2):190-6. doi: 10.1016/j.ejim.2008.06.004. Epub 2008 Oct 11. Eur J Intern Med. 2009. PMID: 19327611
BACKGROUND: Overlap syndrome is a term used for overlapping features of autoimmune hepatitis and primary sclerosing cholangitis or primary biliary cirrhosis and for autoimmune cholangitis. ...
BACKGROUND: Overlap syndrome is a term used for overlapping features of autoimmune hepatitis and primary sclerosing cholangitis or pr …
Histological and virological long-term outcome in patients treated with interferon-alpha2b and ribavirin for chronic hepatitis C.
Schvarcz R, Glaumann H, Reichard O, Weiland O. Schvarcz R, et al. Among authors: glaumann h. J Viral Hepat. 1999 May;6(3):237-42. doi: 10.1046/j.1365-2893.1999.00156.x. J Viral Hepat. 1999. PMID: 10607236 Clinical Trial.
Long-term virological and histological outcome following interferon-alpha2b (IFN-alpha2b) and ribavirin treatment for 24 weeks was studied in 20 patients with chronic hepatitis C who were without a lasting response to IFN as monotherapy. ...Eleven of these patients remaine …
Long-term virological and histological outcome following interferon-alpha2b (IFN-alpha2b) and ribavirin treatment for 24 weeks was st …
Long-term follow-up of chronic hepatitis C patients with sustained virological response to alpha-interferon.
Reichard O, Glaumann H, Frydén A, Norkrans G, Wejstål R, Weiland O. Reichard O, et al. Among authors: glaumann h. J Hepatol. 1999 May;30(5):783-7. doi: 10.1016/s0168-8278(99)80129-9. J Hepatol. 1999. PMID: 10365802 Clinical Trial.
BACKGROUND/AIMS: This study aimed to determine the long-term outcome of hepatitis C virus (HCV)-infected patients who respond to interferon treatment with clearance of serum HCV RNA. ...RESULTS: At biochemical and virological long-term follow-up performed in 26 sust …
BACKGROUND/AIMS: This study aimed to determine the long-term outcome of hepatitis C virus (HCV)-infected patients who respond to inte …
Two-year biochemical, virological, and histological follow-up in patients with chronic hepatitis C responding in a sustained fashion to interferon alfa-2b treatment.
Reichard O, Glaumann H, Frydén A, Norkrans G, Schvarcz R, Sönnerborg A, Yun ZB, Weiland O. Reichard O, et al. Among authors: glaumann h. Hepatology. 1995 Apr;21(4):918-22. Hepatology. 1995. PMID: 7705800
All 14 patients had normal serum alanine transaminase (s-ALT) levels and were negative for hepatitis C virus (HCV) RNA in serum during treatment and at short-term follow-up 6 months post-treatment. At 2-year follow-up, 13 patients still had normal ALT levels (< 0.6 muka …
All 14 patients had normal serum alanine transaminase (s-ALT) levels and were negative for hepatitis C virus (HCV) RNA in serum during treat …
22 results